The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 18, 2025

Filed:

Sep. 10, 2018
Applicant:

Amgen Inc., Thousand Oaks, CA (US);

Inventor:

Clea Talley, Camarillo, CA (US);

Assignee:

AMGEN INC., Thousand Oaks, CA (US);

Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/19 (2006.01); A61K 38/19 (2006.01); A61K 39/395 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01); C07K 14/52 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01);
U.S. Cl.
CPC ...
A61K 9/19 (2013.01); A61K 38/196 (2013.01); A61K 39/395 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01); C07K 14/524 (2013.01); C07K 16/2809 (2013.01); C07K 16/2848 (2013.01); C07K 16/2863 (2013.01); C07K 16/2878 (2013.01); C07K 16/32 (2013.01);
Abstract

This invention concerns a process for making a lyophilized pharmaceutical formulation of a therapeutic protein, which comprises (a) providing a formulation of a bulk amount of the therapeutic protein, (b) measuring the concentration of the therapeutic protein in said bulk formulation, (c) adjusting the fill weight of the protein in said bulk formulation to achieve a fixed dose of the protein, and (d) lyophilizing the protein fill weight-adjusted formulation to achieve a final formulation in a container, wherein the product concentration post reconstitution with a fixed volume is within a predetermined acceptance range. The process is particularly suitable for formulations with low protein concentrations (e.g., 0.05 mg/mL to 20 mg/mL).


Find Patent Forward Citations

Talley, Clea. (2025). Process for lyophilized pharmaceutical formulations of a therapeutic protein (U.S. Patent No. 12251474). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12251474

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…